DiaMedica's Discussion of Preeclampsia Study Part 1a Interim Results

DiaMedica Therapeutics Virtual KOL Event

H.C. Wainwright 3rd Annual BioConnect Conference (Webcast Replay Available)

DiaMedica Corporate Presentation

Interim Phase 2 (Part 1a) Preeclampsia Data

White Paper: The Potential of DM199 to Treat Preeclampsia

11th European Stroke Organisation Conference 2025 Poster

ReMEDy2 Update

DM199 ReMEDy2 Booklet

International Stroke Conference 2024 Poster

Second Quarter 2025 Financial Results Conference Call

Dial In: (800) 836-8184
Conference ID: 29006

A telephonic replay of the conference call will be available until August 20, 2025, by dialing (888) 660-6345 (US Toll Free) and entering the replay passcode: 29006#.

Cantor Global Healthcare Conference 2025

New York City, NY

American Association of Neuroscience Nurses (AANN) Advances in Stroke Care Conference

Conference Call to Discuss Interim Phase 2 Preeclampsia Results

DiaMedica's Discussion of Preeclampsia Study Part 1a Interim Results

Leerink Partners Therapeutics Forum: I&I and Metabolism

Jefferies Global Healthcare Conference 2025

22nd Annual Craig-Hallum Institutional Investor Conference

DiaMedica Therapeutics Virtual KOL Event

11th European Stroke Organisation Conference

H.C. Wainwright 3rd Annual BioConnect Conference (Webcast Replay Available)

2025 RBC Capital Markets Global Healthcare Conference

2025 Annual General Meeting of Shareholders

First Quarter 2025 Financial Results Conference Call

Fourth Quarter 2024 Financial Results Conference Call

Oppenheimer 35th Annual Healthcare Life Sciences Conference